10.08.2023 - • Quarter highlighted by the Emergency Use Authorization (EUA) and commercial launch of Gohibic (vilobelimab) in the United States • Oral C5aR inhibitor INF904 progressing in single ascending dose (SAD) and multiple ascending .
InflaRx Appoints Dr Camilla Chong as Chief Medical Officer tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Amgen Inc. (NASDAQ:NASDAQ:AMGN) Q3 2022 Earnings Conference Call November 03, 2022, 04:30 PM ET Company Participants Arvind Sood - VP, IR Bob Bradway - Chairman and CEO Peter Griffith - CFO.